TSE:GEN - GeneNews Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$0.05 -0.01 (-16.67 %) (As of 02/15/2019 04:00 PM ET)Previous CloseC$0.06Today's RangeC$0.05 - C$0.0652-Week RangeC$0.03 - C$0.17Volume95,000 shsAverage Volume646,431 shsMarket CapitalizationC$7.18 millionP/E Ratio-1.47Dividend YieldN/ABetaN/A ProfileDiscussionChartEarningsHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is based in Richmond Hill, Canada. Receive GEN News and Ratings via Email Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolTSE:GEN Previous Symbol CUSIPN/A Webwww.genenews.com Phone+1-905-7392030Debt Debt-to-Equity RatioN/A Current Ratio0.08 Quick Ratio0.01Price-To-Earnings Trailing P/E Ratio-1.47 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$169,018.00 Price / Sales42.48 Cash FlowC$0.01 per share Price / Cash Flow8.00 Book ValueC($0.04) per share Price / Book-1.39Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees16 Outstanding Shares143,588,000Market CapC$7.18 million OptionableOptionable GeneNews (TSE:GEN) Frequently Asked Questions What is GeneNews' stock symbol? GeneNews trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GEN." When is GeneNews' next earnings date? GeneNews is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for GeneNews. Has GeneNews been receiving favorable news coverage? News articles about GEN stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. GeneNews earned a daily sentiment score of 1.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 3.0 out of 10, meaning that recent press coverage is unlikely to have an impact on the company's share price in the next few days. Who are some of GeneNews' key competitors? Some companies that are related to GeneNews include Sernova (SVA), Smiles Inclusive (SIL), LED Medical Diagnostics (LMD), SQI Diagnostics (SQD), Dorsavi (DVL), VentriPoint Diagnostics (VPT), 3D Signatures (DXD), Imaging Dynamics (IDL), Med Biogene (MBI), BioMark Diagnostics (BUX), BioNano Genomics (BNGOU), Breathtec Biomedical (BTH), Cambridge Cognition (COG), Carl Data Solutions (CRL) and Carl Zeiss Meditec (AFX). Who are GeneNews' key executives? GeneNews' management team includes the folowing people: Mr. James R. Howard-Tripp, Exec. Chairman & CEOMs. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDLProf. Choong-Chin Liew Ph.D., Co-FounderMr. Warren Whitehead, Chief Accountant (Age 67)Mr. David Suria, Sr. Scientist How do I buy shares of GeneNews? Shares of GEN and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is GeneNews' stock price today? One share of GEN stock can currently be purchased for approximately C$0.05. How big of a company is GeneNews? GeneNews has a market capitalization of C$7.18 million and generates C$169,018.00 in revenue each year. GeneNews employs 16 workers across the globe. What is GeneNews' official website? The official website for GeneNews is http://www.genenews.com. How can I contact GeneNews? GeneNews' mailing address is 445 Apple Creek Blvd Unit 220, MARKHAM, ON L3R 9X7, Canada. The company can be reached via phone at +1-905-7392030. MarketBeat Community Rating for GeneNews (TSE GEN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 55 (Vote Outperform)Underperform Votes: 67 (Vote Underperform)Total Votes: 122MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/15/2019 by MarketBeat.com StaffFeatured Article: What are the economic characteristics of a bear market?